In contrast to our finding, another study reported downregulated serum miR-18a in T2DM, suggesting that miR-18a might improve insulin sensitivity via inhibition of PTEN, a known negative regulator of insulin sensitivity [44]. Here, PTEN is linked to type 2 diabetes mellitus.